These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8677872)

  • 1. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension.
    Gharavi AG; Lipkowitz MS; Diamond JA; Jhang JS; Phillips RA
    Am J Cardiol; 1996 Jun; 77(15):1315-9. PubMed ID: 8677872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.
    Pontremoli R; Sofia A; Tirotta A; Ravera M; Nicolella C; Viazzi F; Bezante GP; Borgia L; Bobola N; Ravazzolo R; Sacchi G; Deferrari G
    J Am Soc Nephrol; 1996 Dec; 7(12):2550-8. PubMed ID: 8989733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus.
    Estacio RO; Jeffers BW; Havranek EP; Krick D; Raynolds M; Schrier RW
    Am J Hypertens; 1999 Jun; 12(6):637-42. PubMed ID: 10371375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients.
    Perticone F; Ceravolo R; Cosco C; Trapasso M; Zingone A; Malatesta P; Perrotti N; Tramontano D; Mattioli PL
    J Am Coll Cardiol; 1997 Feb; 29(2):365-9. PubMed ID: 9014990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes.
    Kasikcioglu E; Kayserilioglu A; Ciloglu F; Akhan H; Oflaz H; Yildiz S; Peker I
    Heart Vessels; 2004 Nov; 19(6):287-93. PubMed ID: 15799176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension.
    Celentano A; Mancini FP; Crivaro M; Palmieri V; Ferrara LA; De Stefano V; Di Minno G; de Simone G
    Am J Cardiol; 1999 Apr; 83(8):1196-200. PubMed ID: 10215283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
    Rugale C; du Cailar G; Ribstein J; Mimran A
    Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the angiotensin I converting enzyme insertion/deletion polymorphism, plasma angiotensin converting enzyme activity, and left ventricular mass in a normotensive Chilean population.
    Jalil JE; Piddo AM; Cordova S; Chamorro G; Braun S; Jalil R; Vega J; Jadue'P L; Lavandero S; Lastra P
    Am J Hypertens; 1999 Jul; 12(7):697-704. PubMed ID: 10411367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele.
    Prasad N; O'Kane KP; Johnstone HA; Wheeldon NM; McMahon AD; Webb DJ; MacDonald TM
    QJM; 1994 Nov; 87(11):659-62. PubMed ID: 7820539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
    Sasaki M; Oki T; Iuchi A; Tabata T; Yamada H; Manabe K; Fukuda K; Abe M; Ito S
    J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ACE gene polymorphism correlation (I/D) with the ventricular function in patients with ischemic and idiopathic dilated cardiomyopathy].
    Avila-Vanzzini N; Espínola-Zavaleta N; Masso-Rojas F; Varela-López E; Casanova-Garcés JM; Kury-Alfaro J; Herrera-Bello H
    Rev Invest Clin; 2006; 58(1):39-46. PubMed ID: 16789598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension.
    Pontremoli R; Ravera M; Viazzi F; Nicolella C; Berruti V; Leoncini G; Giacopelli F; Bezante GP; Sacchi G; Ravazzolo R; Deferrari G
    Kidney Int; 2000 Feb; 57(2):561-9. PubMed ID: 10652033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene.
    Hernández D; Lacalzada J; Rufino M; Torres A; Martín N; Barragán A; Barrios Y; Macía M; de Bonis E; Lorenzo V; Rodríguez A; González-Posada JM; Salido E
    Kidney Int; 1997 Apr; 51(4):1205-11. PubMed ID: 9083287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy.
    Iwai N; Ohmichi N; Nakamura Y; Kinoshita M
    Circulation; 1994 Dec; 90(6):2622-8. PubMed ID: 7994801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
    Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
    Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the I/D angiotensin-converting enzyme genotype for detecting the risk of left ventricular hypertrophy in pharmacologically treated hypertensive men.
    López-Contreras J; Blanco-Vaca F; Borrás X; Carreras F; Pons-Lladó G; Gallego F; Solé MJ; Cirera S; Benet MT; Negredo E; Roca-Cusachs A
    J Hum Hypertens; 2000 May; 14(5):327-31. PubMed ID: 10822320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.